charges related to drug safety. Merck, Sun in licence pact for skin drug
MUMBAI (TIP): US-based Merck and Sun Pharma have entered into an exclusive worldwide licensing agreement for Merck’s dermatology molecule, tildrakizumab, which is under phase 3 registration trials. Tildrakizumab is being developed for the treatment of […]
